4D Molecular Therapeutics (FDMT)
(Delayed Data from NSDQ)
$9.97 USD
-0.37 (-3.58%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $9.99 +0.02 (0.20%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.67 |
EPS Last Quarter | -0.63 |
Last EPS Surprise | 12.50% |
ABR | 1.30 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.74 |
Next Year | -2.84 |
EPS (TTM) | -2.30 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.27M | 3.70M | 5.11M | 10.88M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 3.30M | 9.70M | 13.00M | 16.90M |
Low Estimate | 0.01M | 0.01M | 0.05M | 2.00M |
Year ago Sales | 20.20M | -0.02M | 20.72M | 5.11M |
Year over Year Growth Est. | -93.71% | 18,615.00% | -75.33% | 112.73% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.67 | -0.70 | -2.74 | -2.84 |
# of Estimates | 4 | 3 | 6 | 4 |
Most Recent Consensus | -0.65 | -0.66 | -2.68 | -2.94 |
High Estimate | -0.63 | -0.59 | -2.51 | -0.91 |
Low Estimate | -0.70 | -0.85 | -3.07 | -4.27 |
Year ago EPS | -0.24 | -0.77 | -2.58 | -2.74 |
Year over Year Growth Est. | -179.17% | 9.09% | -6.20% | -3.65% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 5 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.67 | -0.70 | -2.74 | -2.84 |
7 Days Ago | -0.67 | -0.70 | -2.74 | -2.84 |
30 Days Ago | -0.67 | -0.70 | -2.75 | -2.84 |
60 Days Ago | -0.74 | -0.75 | -2.93 | -3.09 |
90 Days Ago | -0.74 | -0.75 | -2.93 | -3.09 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.67 | -0.70 | -2.68 | -2.84 |
Zacks Consensus Estimate | -0.67 | -0.70 | -2.74 | -2.84 |
Earnings ESP | 0.00% | 0.00% | 2.19% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.63 | -0.66 | -0.77 | -0.24 | NA |
Estimate | -0.72 | -0.73 | -0.68 | -0.67 | NA |
Difference | 0.09 | 0.07 | -0.09 | 0.43 | 0.13 |
Surprise | 12.50% | 9.59% | -13.24% | 64.18% | 18.26% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more